MacroGenics Announces MGC018 Publication in Molecular Cancer Therapeutics
September 23, 2020 07:15 ET
|
MacroGenics, Inc.
Manuscript describes preclinical development of MGC018Phase 1 dose expansion trial evaluating MGC018 in patients with mCRPC, TNBC and NSCLC is currently recruiting patients ROCKVILLE, MD,...